Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

What really is blood compatibility?

M V Sefton1, C H Gemmell, M B Gorbet

  • 1Department of Chemical Engineering and Applied Chemistry, Institute of Biomaterials and Biomedical Engineering, University of Toronto, Canada.

Journal of Biomaterials Science. Polymer Edition
|March 27, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of contact lens material on cytotoxicity potential of multipurpose solutions using human corneal epithelial cells.

Molecular vision·2012
Same author

Methods for Microencapsulation with HEMA-MMA.

Methods in molecular medicine·2011
Same author

Fibronectin coating of collagen modules increases in vivo HUVEC survival and vessel formation in SCID mice.

Acta biomaterialia·2010
Same author

Corneal epithelial cell biocompatibility to silicone hydrogel and conventional hydrogel contact lens packaging solutions.

Molecular vision·2010
Same author

Complement inhibition reduces material-induced leukocyte activation with PEG modified polystyrene beads (Tentagel) but not polystyrene beads.

Journal of biomedical materials research. Part A·2005
Same author

Viability of hydroxyethyl methacrylate-methyl methacrylate-microencapsulated PC12 cells after omental pouch implantation within agarose gels.

Tissue engineering·2003

Traditional nonthrombogenicity criteria are inadequate. This study redefines nonthrombogenicity using specific thrombin, platelet, complement, and leukocyte activation markers for developing advanced biomaterials.

Area of Science:

  • Biomaterials Science
  • Hemostasis and Thrombosis Research
  • Medical Device Development

Background:

  • Classical nonthrombogenicity criteria (long clotting times, minimal platelet deposition) have hindered progress in developing truly nonthrombogenic materials.
  • Existing criteria are insufficient to guide the development of effective blood-contacting medical devices.

Purpose of the Study:

  • To propose a revised, more effective set of criteria for defining nonthrombogenicity.
  • To establish clear targets for the rational design of advanced biomaterials with improved hemocompatibility.

Main Methods:

  • Re-evaluation of classical nonthrombogenicity metrics.
  • Definition of new quantitative parameters including thrombin production rate constant (kp), platelet consumption and activation (microparticle formation), platelet spreading, and complement/leukocyte activation.

Related Experiment Videos

Main Results:

  • Identified inadequacy of classical criteria for assessing material nonthrombogenicity.
  • Proposed a multi-parameter definition of nonthrombogenicity focusing on dynamic biological responses rather than static clotting times.

Conclusions:

  • A refined definition of nonthrombogenicity is essential for significant advancements in biomaterial development.
  • The proposed criteria provide a clearer target for designing materials with superior hemocompatibility for medical applications.